AlgoNomics To Enter Research Collaboration with Genmab A/S
GENT, Belgium--(BUSINESS WIRE)--AlgoNomics NV today announced it has entered into a research collaboration with Genmab A/S. In the collaboration, AlgoNomics will employ its antibody structure database and Tripole® technology to assist Genmab in research related to the structural analysis of Genmab’s proprietary antibody scaffolds, including the UniBody® technology.